tetano
Editor, Senior Moderator
J Gastrointest Oncol
. 2023 Oct 31;14(5):2146-2157.
doi: 10.21037/jgo-23-641. Epub 2023 Oct 24. Transmembrane serine protease 2, a SARS-CoV-2 internalization protease, correlates with clinical outcome, molecular features, and immunotherapy response in colorectal cancer
Chenjing Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Jianfeng Wu[SUP] #[/SUP][SUP] 1 [/SUP], Vishal G Shelat[SUP] 2 [/SUP], José María Sayagués[SUP] 3 [/SUP], Seiichiro Yamamoto[SUP] 4 [/SUP], Li Yang[SUP] 5 [/SUP], Xia He[SUP] 1 [/SUP]
Affiliations
Background: Transmembrane serine protease 2 (TMPRSS2) mediates the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells. The relevant research indicates the intestine to be a target of SARS-CoV-2 infection, and thus we aimed to investigate the correlation between TMPRSS2 expression and the prognosis, molecular features, and immunotherapy response in patients with colorectal cancer (CRC).
Methods: The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were used in this study and a total of 1,385 patients were identified. The CIBERSORT algorithms were used to evaluate the relative infiltration levels of immune cell types in the tumor microenvironment (TME). The correlation between TMPRSS2 expression and immunotherapy response rate was assessed in another 2 independent cohorts.
Results: TMPRSS2 expression was significantly downregulated in cancer tissue compared to the adjacent normal tissue, and patients with CRC with lower TMPRSS2 expression showed notably poorer prognosis. Functional enrichment analysis found that low TMPRSS2 expression was significantly associated with cancer metastasis-related pathways. Further analysis based on the miRWalk tool and JASPAR database identified a list of microRNAs (miRNAs) and transcriptional factors targeting TMPRSS2. Distinct differences in immune cell infiltration and tumor purity reflected by estimate and mutant-allele tumor heterogeneity score were observed between patients with low and high TMPRSS2 expression levels. Interestingly, patients with a low TMPRSS2 expression level showed a higher response rate to immunotherapy.
Conclusions: CRC cells may be more resistant to SARS-CoV-2 infection due to the decreased expression of TMPRSS2, which could be a newly identified biomarker for prognosis and immunotherapy response prediction in patients with CRC.
Keywords: Colorectal cancer (CRC); immunotherapy; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); transmembrane serine protease 2 (TMPRSS2); tumor microenvironment (TME).
. 2023 Oct 31;14(5):2146-2157.
doi: 10.21037/jgo-23-641. Epub 2023 Oct 24. Transmembrane serine protease 2, a SARS-CoV-2 internalization protease, correlates with clinical outcome, molecular features, and immunotherapy response in colorectal cancer
Chenjing Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Jianfeng Wu[SUP] #[/SUP][SUP] 1 [/SUP], Vishal G Shelat[SUP] 2 [/SUP], José María Sayagués[SUP] 3 [/SUP], Seiichiro Yamamoto[SUP] 4 [/SUP], Li Yang[SUP] 5 [/SUP], Xia He[SUP] 1 [/SUP]
Affiliations
- PMID: 37969833
- PMCID: PMC10643587
- DOI: 10.21037/jgo-23-641
Background: Transmembrane serine protease 2 (TMPRSS2) mediates the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells. The relevant research indicates the intestine to be a target of SARS-CoV-2 infection, and thus we aimed to investigate the correlation between TMPRSS2 expression and the prognosis, molecular features, and immunotherapy response in patients with colorectal cancer (CRC).
Methods: The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were used in this study and a total of 1,385 patients were identified. The CIBERSORT algorithms were used to evaluate the relative infiltration levels of immune cell types in the tumor microenvironment (TME). The correlation between TMPRSS2 expression and immunotherapy response rate was assessed in another 2 independent cohorts.
Results: TMPRSS2 expression was significantly downregulated in cancer tissue compared to the adjacent normal tissue, and patients with CRC with lower TMPRSS2 expression showed notably poorer prognosis. Functional enrichment analysis found that low TMPRSS2 expression was significantly associated with cancer metastasis-related pathways. Further analysis based on the miRWalk tool and JASPAR database identified a list of microRNAs (miRNAs) and transcriptional factors targeting TMPRSS2. Distinct differences in immune cell infiltration and tumor purity reflected by estimate and mutant-allele tumor heterogeneity score were observed between patients with low and high TMPRSS2 expression levels. Interestingly, patients with a low TMPRSS2 expression level showed a higher response rate to immunotherapy.
Conclusions: CRC cells may be more resistant to SARS-CoV-2 infection due to the decreased expression of TMPRSS2, which could be a newly identified biomarker for prognosis and immunotherapy response prediction in patients with CRC.
Keywords: Colorectal cancer (CRC); immunotherapy; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); transmembrane serine protease 2 (TMPRSS2); tumor microenvironment (TME).